Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Classement en actions #17187
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Prix de l'action
$2.20
Dernière synchronisation: 2026-09-01
Capitalisation boursière
$253.81M
Changement (1 jour)
10.29%
Changement (1 an)
99.67%
Pays
CA
Échange Cardiol Therapeutics Inc. (CRDL)

Catégorie

Le prix CRDL avec la capitalisation boursière de B
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
CRDL
$2.20
Capitalisation boursière de Cardiol Therapeutics Inc.(CRDL)
Capitalisation boursière: $253.81M
En September 2026, Cardiol Therapeutics Inc. a une capitalisation boursière de $253.81M. Cela fait de Cardiol Therapeutics Inc. la 17187th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Cardiol Therapeutics Inc. du 2018 au 2026
CRDL par rapport au top 5 des plus populaires stocks
Prix pour CRDL L’actif B La capitalisation boursière de B Résultats
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$45,627.72 $253.81M
$5.260T +2,072,181.83%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$41,454.31 $253.81M
$4.779T +1,882,637.41%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$34,845.69 $253.81M
$4.017T +1,582,492.63%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$32,265.44 $253.81M
$3.719T +1,465,304.86%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$23,719.85 $253.81M
$2.734T +1,077,188.17%